United Therapeutics Corporation ( UTHR) - Key Metrics

UTHR Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $18.39 $7.82 $7.36 $4.83
2026Q1 $17.97 $6.32 $10.65 $8.33
2025Q4 $17.84 $8.22 $7.81 $3.91
2025Q3 $18.25 $7.73 $12.83 $8.03
2025Q2 $17.71 $6.86 $4.25 $2.87

UTHR Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 17.32
2026Q1 0% 23.46
2025Q4 0% 14.57
2025Q3 0% 13.56
2025Q2 0% 10.47

UTHR Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.89% 0%
2026Q1 1.41% 0%
2025Q4 0.80% 0%
2025Q3 1.91% 0%
2025Q2 1.00% 0%

UTHR

Price: $499.73

52 week price:
292.34
609.35

Earnings Per Share: 27.93 USD

P/E Ratio: 18.46

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 115651

Ebitda: 331.7 million

Market Capitalization: 22.1 billion

Links: